drugset / Trial / NCT01722513
Efficacy and Safety of Alprostadil Prevent Contrast Induced Nephropathy
NaSingle-groupSingle-blindPrevention
Summary
The aim of this prospective, randomized, controlled study is to investigate the effect of pretreatment with intravenous Alprostadil on the incidence of CIN in a high-risk population of patients with both type 2 diabetes mellitus (T2DM) and CKD undergoing coronary angiography, and evaluate the influence of such potential benefit on short-term outcome.
Timeline
- Start
- 2012-11
- Primary completion
- 2013-11
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alprostadil | Unknown | 40 ug | Intravenous |